EUVIMEDEUVIMED entdecken
Open Access

Energy‑stress‑mediated activation of AMPK sensitizes MPS1 kinase inhibition in triple‑negative breast cancer

Jong Seung Lim, Eunkyoung Kim, Jin-Sook Song, Sunjoo Ahn

Oncology Reports · 2024

DOI: 10.3892/or.2024.8760 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Reports, 2024. Verfasst von Jong Seung Lim und 3 weiteren Autor:innen. Beteiligte Einrichtung: Therapeutics & Biotechnology Division, Korea Research Institute of Chemical Technology, Daejeon 34114, Republic of Korea. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Aminoimidazole Carboxamide, AMP-Activated Protein Kinases, Xenograft Model Antitumor Assays. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Monopolar spindle 1 kinase (Mps1, also known as TTK protein kinase) inhibitors exert marked anticancer effects against triple‑negative breast cancer (TNBC) by causing genomic instability and cell death. As aneuploid cells are vulnerable to compounds that induce energy stress through adenosine monophosphate‑activated protein kinase (AMPK) activation, the synergistic effect of Mps1/TTK inhibition and AMPK activation was investigated in the present study. The combined effects of CFI‑402257, an Mps1/TTK inhibitor, and AICAR, an AMPK agonist, were evaluated in terms of cytotoxicity, cell‑cycle distribution, and in vivo xenograft models. Additional molecular mechanistic studies were conducted to elucidate the mechanisms underlying apoptosis and autophagic cell death. The combination of CFI‑402257 and AICAR showed selective cytotoxicity in a TNBC cell line. The formation of polyploid cells was attenuated, and apoptosis was increased by the combination treatment, which also induced autophagy through dual inhibition of the PI3K/Akt/mTOR and mitogen‑activated protein kinase (MAPK) signaling pathways. Additionally, the combination therapy showed strongly improved efficacy in comparison with CFI‑402257 and AICAR monotherapy in the MDA‑MB‑231 xenograft model. The present study suggested that the combination of CFI‑402257 and AICAR is a promising therapeutic strategy for TNBC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Triple Negative Breast NeoplasmsAminoimidazole CarboxamideAMP-Activated Protein KinasesXenograft Model Antitumor AssaysRibonucleotidesProtein Serine-Threonine KinasesCell Cycle ProteinsApoptosisAutophagyHumansFemaleAnimalsMiceCell Line, TumorProtein-Tyrosine KinasesProtein Kinase InhibitorsCell ProliferationSignal TransductionDrug SynergismBiphenyl CompoundsPyronesThiophenes

Stichwörter der Autor:innen

AMPKMPS1 kinaseTNBCTTK protein kinasebreast cancerenergy stress

Substanzen

TTK protein, humanAminoimidazole CarboxamideAMP-Activated Protein KinasesRibonucleotidesProtein Serine-Threonine KinasesAICA ribonucleotideCell Cycle ProteinsProtein-Tyrosine KinasesProtein Kinase Inhibitors4-hydroxy-3-(4-(2-hydroxyphenyl)phenyl)-6-oxo-7H-thieno(2,3-b)pyridine-5-carbonitrile

Autor:innen und Institutionen

  • Therapeutics & Biotechnology Division, Korea Research Institute of Chemical Technology, Daejeon 34114, Republic of Korea.

Zitieren

APA

Lim, J. S., Kim, E., Song, J. S., & Ahn, S. (2024). Energy‑stress‑mediated activation of AMPK sensitizes MPS1 kinase inhibition in triple‑negative breast cancer. Oncology Reports. https://doi.org/10.3892/or.2024.8760

Vancouver

Lim JS, Kim E, Song JS, Ahn S. Energy‑stress‑mediated activation of AMPK sensitizes MPS1 kinase inhibition in triple‑negative breast cancer. Oncology Reports. 2024. doi:10.3892/or.2024.8760

BibTeX
@article{Lim2024,
  author = {Lim, Jong Seung and Kim, Eunkyoung and Song, Jin-Sook and Ahn, Sunjoo},
  title = {Energy‑stress‑mediated activation of AMPK sensitizes MPS1 kinase inhibition in triple‑negative breast cancer},
  journal = {Oncology Reports},
  year = {2024},
  doi = {10.3892/or.2024.8760}
}
Kostenlos starten →